Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
53,000
Employees53,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
53,000
Employees53,000

BSX Key Statistics

Market cap
141.40B
Market cap141.40B
Price-Earnings ratio
51.35
Price-Earnings ratio51.35
Dividend yield
Dividend yield
Average volume
7.84M
Average volume7.84M
High today
$96.33
High today$96.33
Low today
$95.28
Low today$95.28
Open price
$96.16
Open price$96.16
Volume
4.04M
Volume4.04M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$85.98
52 Week low$85.98

Stock Snapshot

With a market cap of 141.4B, Boston Scientific(BSX) trades at $95.35. The stock has a price-to-earnings ratio of 51.35.

During the trading session on 2026-01-01, Boston Scientific(BSX) shares reached a daily high of $96.33 and a low of $95.28. At a current price of $95.35, the stock is +0.1% higher than the low and still -1.0% under the high.

Trading volume for Boston Scientific(BSX) stock has reached 4.04M, versus its average volume of 7.84M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $85.98.

BSX News

Nasdaq 1d
How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?

Boston Scientific’s BSX Cardiovascular segment operates in a $50 billion market, projected to grow nearly 9% over the 2026-2028 long-range plan (LRP). Managemen...

How Is Boston Scientific's Cardiovascular Growth Path Shaping Up?
Nasdaq 3d
Peter Lynch Detailed Fundamental Analysis - BSX

Below is Validea's guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow, BSX rates highest using our P/E/Growth Investo...

Peter Lynch Detailed Fundamental Analysis - BSX

Analyst ratings

94%

of 36 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.